Palliative Radiation with a Radiolabeled Diphosphonate (Rhenium-186 Etidronate) in Patients with Hormone-Refractory Disseminated Prostate Carcinoma-Reference-Cited by-同舟云学术

Palliative Radiation with a Radiolabeled Diphosphonate (Rhenium-186 Etidronate) in Patients with Hormone-Refractory Disseminated Prostate Carcinoma

Published:2000-01-01 Issue:3 Volume:34 Page:188-193
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Tennvall Jan¹,Abrahamsson Per-Anders¹,Ahlgren Göran¹,Darte Lennart¹,Flodgren Per¹,Garkavij Michael¹,Strand Sven-Erik¹

Affiliation:

1. Department of Oncology, University Hospital, SE-221 85 Lund, Sweden

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/003655900750016571

Reference20 articles.

1. Targeted radionuclide therapy for bone metastases

2. Nilsson S, Westlin J-E. 89-Strontium treatment in prostatic cancer. In: Pharmacological treatment of prostatic cancer. Medical Product Agency; 1993; Vol 3: 123–7.

3. Results of a randomized phase-III trial to evaluate the efficacy of strontium-89 adjuvant to local field external beam irradiation in the management of endocrine resistant metastatic prostate cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review;European Urology;2016-09

2. Radionuclide Therapy;Bone Metastases;2013-10-11

3. Phase 2 Study of a High Dose of 186Re-HEDP for Bone Pain Palliation in Patients with Widespread Skeletal Metastases;Journal of Nuclear Medicine Technology;2013-08-05

4. Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases;Cancer Letters;2012-10

5. Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain;Seminars in Nuclear Medicine;2010-03